Cytek Biosciences Management
Management criteria checks 2/4
Cytek Biosciences' CEO is Wenbin Jiang, appointed in Dec 2014, has a tenure of 9.42 years. total yearly compensation is $4.94M, comprised of 11.7% salary and 88.3% bonuses, including company stock and options. directly owns 4.04% of the company’s shares, worth $32.99M. The average tenure of the management team and the board of directors is 2.3 years and 3.2 years respectively.
Key information
Wenbin Jiang
Chief executive officer
US$4.9m
Total compensation
| CEO salary percentage | 11.7% |
| CEO tenure | 9.4yrs |
| CEO ownership | 4.0% |
| Management average tenure | 2.3yrs |
| Board average tenure | 3.2yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$5m | US$578k | -US$12m |
| Sep 30 2023 | n/a | n/a | -US$14m |
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$4m | US$524k | US$2m |
| Sep 30 2022 | n/a | n/a | -US$901k |
| Jun 30 2022 | n/a | n/a | -US$3m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$5m | US$375k | US$52k |
| Sep 30 2021 | n/a | n/a | US$575k |
| Jun 30 2021 | n/a | n/a | US$2m |
| Mar 31 2021 | n/a | n/a | US$4m |
| Dec 31 2020 | US$422k | US$241k | US$3m |
Compensation vs Market: Wenbin's total compensation ($USD4.94M) is above average for companies of similar size in the US market ($USD3.42M).
Compensation vs Earnings: Wenbin's compensation has increased whilst the company is unprofitable.
CEO
Wenbin Jiang (59 yo)
9.4yrs
Tenure
US$4,939,242
Compensation
Dr. Wenbin Jiang, Ph D., is co-founder, Chairman and President of Cytek Biosciences, Inc and has been its Chief Executive Officer and Director since December 2014. Dr. Jiang is a seasoned entrepreneur and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 9.4yrs | US$4.94m | 4.04% $ 33.0m | |
| CTO & Director | 9.3yrs | US$3.07m | 4.56% $ 37.2m | |
| Chief Legal Officer & Corporate Secretary | 3.3yrs | US$1.86m | 0.028% $ 224.9k | |
| Senior Vice President of Business & Corporate Development | 3.1yrs | US$1.43m | 0.039% $ 317.5k | |
| Head of Corporate Development Analytics | less than a year | US$1.79m | 0.074% $ 606.2k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | 1.6yrs | no data | 0.0040% $ 33.1k | |
| Senior Vice President of Global Sales & Services | less than a year | no data | 0.0025% $ 20.7k |
2.3yrs
Average Tenure
57.5yo
Average Age
Experienced Management: CTKB's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 9.4yrs | US$4.94m | 4.04% $ 33.0m | |
| CTO & Director | 9.3yrs | US$3.07m | 4.56% $ 37.2m | |
| Independent Director | 1.9yrs | US$215.67k | 0.011% $ 89.3k | |
| Independent Director | 1.9yrs | US$217.50k | 0.011% $ 89.3k | |
| Lead Independent Director | 5.7yrs | US$260.00k | 0.021% $ 167.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.2yrs | US$232.50k | 0.0038% $ 31.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.4yrs | US$215.00k | 0.0097% $ 79.0k |
3.2yrs
Average Tenure
61yo
Average Age
Experienced Board: CTKB's board of directors are considered experienced (3.2 years average tenure).